Affiris AG
Vienna, AT· latest recorded location
AFFIRIS AG is named on 24 US grants and 42 published applications in this corpus. Its most frequent classification is A61P (Therapeutic uses of medicines).
- Granted patents
- 24
- Published applications
- 42
- Inventors
- 42
- Granted in 2026 so far
- 0
- Most recent grant
- 20 Jul 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 5 |
| 2012 | 0 | 2 |
| 2013 | 3 | 1 |
| 2014 | 1 | 5 |
| 2015 | 3 | 6 |
| 2016 | 1 | 3 |
| 2017 | 4 | 9 |
| 2018 | 4 | 4 |
| 2019 | 4 | 2 |
| 2020 | 2 | 3 |
| 2021 | 2 | 1 |
| 2022 | 0 | 1 |
By publication year.
Technology areas
Share of 66 documents
Recent patents
- Treatment and prevention of alzheimer's disease (AD)20 Jul 2021US 11,065,273 B2
- Peptide vaccines usable for hypercholesterolemia related diseases2 Mar 2021US 10,933,123 B2
- Treatment of alzheimer'S disease (AD) with an aluminum salt12 May 2020US 10,646,565 B2
- IL-23-p19 vaccines3 Mar 2020US 10,576,131 B2
- Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders31 Dec 2019US 10,517,935 B2
- Substances and methods for the use in prevention and/or treatment in huntingon's disease10 Mar 2022US 2022/0073650 A1
- Substances and methods for the use in prevention and/or treatment in huntington's disease11 Feb 2021US 2021/0040236 A1
- Treatment and prevention of alzheimer's disease (ad)29 Oct 2020US 2020/0338192 A1
- Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders13 Aug 2020US 2020/0254076 A1
- Il-23-p19 vaccines16 Jan 2020US 2020/0016249 A1
Most cited
By later US patents
- Compounds for treating beta-amyloidoses5US 8,613,931 B22013
- Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders4US 9,724,399 B22017
- Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders2US 10,517,935 B22019
- Substances and methods for the use in prevention and/or treatment in Huntington's disease1US 10,053,518 B22018
- Substances and methods for the use in prevention and/or treatment in Huntington's disease1US 10,406,197 B22019